Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Andus

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
European Journal of Biochemistry|May 2, 1988
Involvement of various organs in the initial plasma clearance of differently glycosylated rat liver secretory proteinsV Gross, P C Heinrich, D vom Berg, et al.
International Journal of Colorectal Disease|September 19, 2003
Analysis of the therapeutic efficacy of different doses of budesonide in patients with active Crohn's ileocolitis depending on disease activity and localizationH Herfarth, V Gross, T Andus, et al.
FEBS Letters|January 2, 1989
Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytesJ V Castell, M J Gómez-Lechón, M David, et al.
Hepato-Gastroenterology|March 1, 1997
Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study GroupI Caesar, V Gross, M Roth, et al.
Zeitschrift Fur Gastroenterologie|May 1, 1995
Treatment of active Crohn's ileocolitis with oral pH-modified budesonide. Germany Budesonide Study GroupI Caesar, V Gross, M Roth, et al.
Biochimica Et Biophysica Acta|November 9, 1990
Hepatocyte specific long lasting inhibition of protein N-glycosylation by D-galactosamineV Gross, D Ludolph, D Vom Berg, et al.
European Journal of Clinical Investigation|May 7, 1999
Glucocorticoid receptors are down-regulated in inflamed colonic mucosa but not in peripheral blood mononuclear cells from patients with inflammatory bowel diseaseG Rogler, A Meinel, A Lingauer, et al.
Digestive Diseases and Sciences|March 20, 2003
Replacement of conventional glucocorticoids by oral pH-modified release budesonide in active and inactive Crohn's disease: results of an open, prospective, multicenter trialT Andus, V Gross, I Caesar, et al.
Gastroenterology|July 25, 1998
Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosaG Rogler, K Brand, D Vogl, et al.
Gastroenterology|June 11, 2002
Toll-like receptors 2 and 4 are up-regulated during intestinal inflammationM Hausmann, S Kiessling, S Mestermann, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
European Journal of Biochemistry|May 2, 1988
Involvement of various organs in the initial plasma clearance of differently glycosylated rat liver secretory proteinsV Gross, P C Heinrich, D vom Berg, et al.
International Journal of Colorectal Disease|September 19, 2003
Analysis of the therapeutic efficacy of different doses of budesonide in patients with active Crohn's ileocolitis depending on disease activity and localizationH Herfarth, V Gross, T Andus, et al.
FEBS Letters|January 2, 1989
Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytesJ V Castell, M J Gómez-Lechón, M David, et al.
Hepato-Gastroenterology|March 1, 1997
Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study GroupI Caesar, V Gross, M Roth, et al.
Zeitschrift Fur Gastroenterologie|May 1, 1995
Treatment of active Crohn's ileocolitis with oral pH-modified budesonide. Germany Budesonide Study GroupI Caesar, V Gross, M Roth, et al.
Biochimica Et Biophysica Acta|November 9, 1990
Hepatocyte specific long lasting inhibition of protein N-glycosylation by D-galactosamineV Gross, D Ludolph, D Vom Berg, et al.
European Journal of Clinical Investigation|May 7, 1999
Glucocorticoid receptors are down-regulated in inflamed colonic mucosa but not in peripheral blood mononuclear cells from patients with inflammatory bowel diseaseG Rogler, A Meinel, A Lingauer, et al.
Digestive Diseases and Sciences|March 20, 2003
Replacement of conventional glucocorticoids by oral pH-modified release budesonide in active and inactive Crohn's disease: results of an open, prospective, multicenter trialT Andus, V Gross, I Caesar, et al.
Gastroenterology|July 25, 1998
Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosaG Rogler, K Brand, D Vogl, et al.
Gastroenterology|June 11, 2002
Toll-like receptors 2 and 4 are up-regulated during intestinal inflammationM Hausmann, S Kiessling, S Mestermann, et al.
Pageof 11